Sign in

CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company

Protagenic Therapeutics, Inc.new

Sign in to watch
Ticker
PTIX
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
061390025
Phone
(212) 994-8200
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Material agreement · Unregistered share sale
  3. DEFA14A Proxy Proxy Materials
  4. 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure · Other events
  5. 10-Q Report Quarterly Report
  6. 8-K Event Bylaws or fiscal year change
  7. 8-K Event Regulation FD disclosure
  8. 8-K Event Shareholder vote results
  9. 10-K Report Annual Report
  10. DEF 14A Proxy Proxy Statement
  11. PRE 14A Proxy Proxy Statement (Preliminary)
  12. 8-K Event Executive or director change
  13. 8-K Event Shareholder vote results
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 8-K Event Delisting notice
  16. 8-K Event Delisting notice
  17. 8-K Event Material agreement
  18. 424B5 Offering Prospectus
  19. EFFECT Other Notice of Effectiveness
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 3 of 36 · 707 filings